loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r0_cep_2001_064___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Biorelease Technologies Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Biorelease Technologies Inc Manchester US (1)

    filter

    01 Modified Bovine Haemoglobin, (Product codes: ERI-01-1000, ERI-01- 500, ERI-01-120) (1)

    filter

    01 U.S.A (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Biorelease Technologies Inc Manches...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Modified Bovine Haemoglobin, (Product codes: ERI-01-100...

      PDF Supplier PDF
      URL Supplier Web Content
      R0-CEP 2001-064 - Rev 00
      Withdrawn by Holder
      TSE
      2001-11-23
      2006-11-24
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2001-064 - Rev 00 of Biorelease Technologies Inc Manchester Us

      Looking for Certificates of Suitability (CEPs) for R0-CEP 2001-064 - Rev 00 of Biorelease Technologies Inc Manchester Us 1

      20

      Biorelease Technologies Inc Manchester Us, based in U.S.A, is a pharmaceutical company.

      One of their significant offerings is Modified Bovine Haemoglobin, (Product codes: ERI-01-1000, ERI-01- 500, ERI-01-120), supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2001-064 - Rev 00

      This TSE Type CEP, issued on November 23, 2001, remains in force until November 24, 2006, ensuring its reliability within the pharmaceutical industry.

      Post Enquiry
      POST ENQUIRY